label int64 1 1 | id stringlengths 10 12 | original_id stringlengths 8 9 | text stringlengths 347 29.5k |
|---|---|---|---|
1 | 172213669_0 | 172213669 | GW PHARMACEUTICALS PLC
Form 20-F
Filed on 04-Dec-2017 Period 30-Sep-2017 Accession number: 0001144204-17-062057
Included Items
1. 20-F 2. EX-4.63: EXHIBIT 4.63 3. EX-4.64: EXHIBIT 4.64 4. EX-4.65: EXHIBIT 4.65 5. EX-4.66: EXHIBIT 4.66 6. EX-4.67: EXHIBIT 4.67 7. EX-4.68: EXHIBIT 4.68 8. EX-4.69: EXHIBIT 4.69 9. EX-4.... |
1 | 172213669_1 | 172213669 | 76: EXHIBIT 4.76 16. EX-4.77: EXHIBIT 4.77 17. EX-4.78: EXHIBIT 4.78 18. EX-4.79: EXHIBIT 4.79 19. EX-4.80: EXHIBIT 4.80 20. EX-4.81: EXHIBIT 4.81 21. EX-4.82: EXHIBIT 4.82 22. EX-4.83: EXHIBIT 4.83 23. EX-8.1: EXHIBIT 8.1 24. EX-12.1: EXHIBIT 12.1 25. EX-12.2: EXHIBIT 12.2 26. EX-13.1: EXHIBIT 13.1 27. EX-13.2: EXHIBI... |
1 | 172213669_2 | 172213669 | -F
REGISTRATION STATEMENTPURSUANTTO SECTION 12(b) OR (g) OF THESECURITIES EXCHANGEACTOF 1934
OR ANNUAL REPORTPURSUANTTO SECTION 13 OR 15(d) OF THESECURITIES EXCHANGEACTOF 1934
For the fiscal year ended September 30, 2017
OR TRANSITION REPORTPURSUANTTO SECTION 13 OR 15(d) OF THESECURITIES EXCHANGEACTOF 1934
OR SHELL... |
1 | 172213669_3 | 172213669 | Kingdom Telephone No. (44) 1223 266800
E-Mail: investors@gwpharm.com Facsimile: (44) 1223 235667
(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)
Securities registered or to be registered pursuant to Section 12(b) of the Act.
Title of each class
Name of each exchange on whic... |
1 | 172213669_b0 | 172213669 | my knowledge, that:
1. The Annual Report on Form 20-F for the year ended September 30, 2017 (the "Form 20-F") of the company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Form 20-F fairly presents, in all material respects... |
1 | 172213669_b1 | 172213669 | itors and the audit committee of the company's board of directors (or persons performing the equivalent functions):
a. all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company's ability to rec... |
1 | 172407304_0 | 172407304 | Altisource Portfolio Solutions S.A.
Form 10-K
Filed on 22-Feb-2018 Period 31-Dec-2017 Accession number: 0001462418-18-000011
Included Items
1. 10-K 2. EX-10.71: EXHIBIT 10.71 3. EX-10.72: EXHIBIT 10.72 4. EX-21.1: EXHIBIT 21.1 5. EX-23.1: EXHIBIT 23.1 6. EX-23.2: EXHIBIT 23.2 7. EX-31.1: EXHIBIT 31.1 8. EX-31.2: EXHI... |
1 | 172407304_1 | 172407304 | ED DECEMBER 31, 2017
OR
o TRANSITION REPORT PURSUANT TO SECTION 13 OR15(d) OF THESECURITIES EXCHANGEACT OF 1934
Commission File Number: 1-34354
ALTISOURCE PORTFOLIO SOLUTIONS S.A.
(Exact name of Registrant as specified in its Charter)
Luxembourg
98-0554932
(State or other jurisdiction of incorporation or organizati... |
1 | 172407304_2 | 172407304 | o No þ
Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o No þ
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by section 13 or 15(d) of the Securities Exchange Act of 1934 during the precedin... |
1 | 172407304_3 | 172407304 | information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. þ
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or emerging growth company (as defined in Rule 12... |
1 | 172407304_b0 | 172407304 | ] The sumof quarterly amounts, including per share amounts, may not equal amounts reported for year-to-date periods. This is due to the effects of rounding and changes in the number of weighted average shares outstanding for each period.
[3] During the fourth quarter of 2016, Altisource recorded a litigation settlement... |
1 | 172407304_b1 | 172407304 |
$ 300,900
$ 300,900
Operating loss carryforwards, term
17 years
[1] On December 27, 2017, two of the Company's wholly-owned subsidiaries, Altisource Solutions S.à r.l. and Altisource Holdings S.à r.l., merged, with Altisource Holdings S.à r.l. as the surviving entity. Altisource Holdings S.à r.l. was subsequently ... |
1 | 172409349_0 | 172409349 | Lyondellbasell Industries N.V.
Form 10-K
Filed on 22-Feb-2018 Period 31-Dec-2017 Accession number: 0001193125-18-054181
Included Items
1. 10-K 2. EX-12.1 3. EX-21 4. EX-23 5. EX-31.1 6. EX-31.2 7. EX-32 8. XBRL (render)
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
For... |
1 | 172409349_1 | 172409349 |
The Netherlands
(State or other jurisdiction of incorporation or organization)
1221 McKinney St., Suite 300
Houston, Texas USA 77010
4th Floor, One Vine Street London W1J0AH
The United Kingdom
98-0646235
(I.R.S. Employer Identification No.)
Delftseplein 27E 3013 AA Rotterdam
The Netherlands
(Address of principal e... |
1 | 172409349_2 | 172409349 | 13 or Section 15(d) of the Act. Yes No
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)... |
1 | 172409349_3 | 172409349 | , an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of " large accelerated filer," " accelerated filer" and " smaller reporting company" in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer Non-accelerated filer
(Do not check if a smaller reporting... |
1 | 172409349_b0 | 172409349 | March 31, 2016 included charges of $ 40 million related to out-of-period adjustments for deferred taxliabilities associated with some of our subsidiaries. We also recognized a pretaxLCM inventory valuation charge of $ 68 million ($ 47 million after tax) in the three months ended March 31, 2016, which was reversed in t... |
1 | 172409349_b1 | 172409349 | liability
Senior Notes due 2019, $2,000 million, 5.0% [Member]
Long-term debt [Line Items]
Redemption of 5% Senior Notes due 2019
Maturity year
Stated interest rate (in hundredths)
$ 819
2019 5.00% 5.00%
58 $ 37 113
106
$ 1,000 2019 5.00%
5.00%
$ 78
$ 819 $ 0 $ 0 2019 2019 5.00% 5.00%
[1] Represents Sales and ot... |
1 | 172410558_0 | 172410558 | Orion Engineered Carbons S.A.
Form 20-F
Filed on 23-Feb-2018 Period 31-Dec-2017 Accession number: 0001609804-18-000009
Included Items
1. 20-F: 20-F 2017 2. EX-8.1: EXHIBIT 8.1 2017 3. EX-12.1: EXHIBIT 12.1 2017 4. EX-12.2: EXHIBIT 12.2 2017 5. EX-13.1: EXHIBIT 13.1 2017 6. EX-13.2: EXHIBIT 13.2 2017 7. EX-15.1: EXHIB... |
1 | 172410558_1 | 172410558 | 15(d) of the Securities Exchange Act of 1934 or
o Shell company report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission file number: 001- 36563
ORION ENGINEERED CARBONS S.A.
(Exact Name of Registrant as Specified in its Charter)
N/A
(Translation of Registrant's Name into English)
Gra... |
1 | 172410558_2 | 172410558 | the Act:
Title of Each Class
Name of Each Exchange On Which Registered
Common Shares, no par value
NewYork Stock Exchange
Securities registered or to be registered pursuant to Section 12(g) of the Act: None
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None
Indicate ... |
1 | 172410558_3 | 172410558 | whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 duringthe preceding12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filingrequirements for the past 90 days. ... |
1 | 172410558_b0 | 172410558 | facilities located in the United States | facility
4
4
US Denominated Credit Facility Term Loan
Disclosure of contingent liabilities [line items]
Current principal amount | $
$ 288,000
EUR Denominated Credit Facility Term Loan
Disclosure of contingent liabilities [line items]
Current principal amount |
320... |
1 | 172410558_b1 | 172410558 | long-term supply agreements
288,373 413,366
Less than one year
Disclosure of maturity analysis for non-derivative financial liabilities [line items]
Raw material commitments under long-term supply agreements
91,059
147,857
1 to 5 years
Disclosure of maturity analysis for non-derivative financial liabilities ... |
1 | 172412357_0 | 172412357 | Continental Building Products, Inc.
Form 10-K
Filed on 23-Feb-2018 Period 31-Dec-2017 Accession number: 0001628280-18-002132
Included Items
1. 10-K 2. EX-21.1: EXHIBIT 21.1 3. EX-23.1: EXHIBIT 23.1 4. EX-31.1: EXHIBIT 31.1 5. EX-31.2: EXHIBIT 31.2 6. EX-32.1: EXHIBIT 32.1 7. XBRL (render)
Table of Contents
As file... |
1 | 172412357_1 | 172412357 | from __________ to __________.
Commission File Number: 001-36293
CONTINENTAL BUILDING PRODUCTS, INC. (Exact name of registrant as specified in its charter)
Delaware (State or other jurisdiction of incorporation) 12950 Worldgate Drive, Suite 700, Herndon, VA
(Address of principal executive offices) (703) 480-3800
(Reg... |
1 | 172412357_2 | 172412357 | Section 13 or Section 15(d) of the Act.
Yes ¨ No x
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports)... |
1 | 172412357_3 | 172412357 | 10-K. ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.
Large accelerated... |
1 | 172412357_b0 | 172412357 | 900) 6 154 (1,196) (5,963) (751)
(2,822) (2,988) (3,062) (2,916) (3,098) (3,146) (3,648) (3,698) (11,788) (13,590) (16,432)
23,186 16,865 18,423 18,127 19,480 9,515 19,566 19,026 76,601 67,587 26,822
(158) (204) 345 (170) (10) (291) (240) (195) (187) (736) (750)
23,028 16,661 18,768 17,957 19,470 9,224 19,326 18,83... |
1 | 172412357_b1 | 172412357 |
Dec. 31, 2015
USD ($) $ /
shares
$
$
$
$
$
$
$
$
$
$
$
131,392 116,526 120,630 120,615 118,217 114,558 117,115 111,485 489,163 461,375 421,682
94,432 87,952 89,817 89,624 85,862 86,756 83,744 79,955 361,825 336,317 312,840
10,389 8,867 9,193 9,304 9,554 9,241 10,163 8,960 37,753 37,918 34,891
104,821 9... |
1 | 172412765_0 | 172412765 | XL GROUP LTD
Form 10-K
Filed on 23-Feb-2018 Period 31-Dec-2017 Accession number: 0000875159-18-000015
Included Items
1. 10-K 2. EX-10.47: EXHIBIT 10.47 3. EX-12: EXHIBIT 12 4. EX-21: EXHIBIT 21 5. EX-23: EXHIBIT 23 6. EX-31: EXHIBIT 31 7. EX-32: EXHIBIT 32 8. XBRL (render)
UNITED STATES SECURITIES AND EXCHANGE COMM... |
1 | 172412765_1 | 172412765 | Bermuda (State or other jurisdiction of incorporation or organization)
98-1304974 (I.R.S. Employer Identification No.)
O'Hara House, One Bermudiana Road, Hamilton HM 08, Bermuda
(Address of principal executive offices and zip code)
(441) 292-8515 (Registrant's telephone number, including area code)
SECURITIES REGIS... |
1 | 172412765_2 | 172412765 | ) OF THE ACT: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes x No ¨
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act. Yes ¨ No x
Indicate by check mark wh... |
1 | 172412765_3 | 172412765 | K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelera... |
1 | 172412765_b0 | 172412765 |
$ 0
$ 0
$ 0
Ceded to other companies, premiums earned
221,944 253,268 247,675
Assumed from other companies, premiums earned
234,278 265,315 309,916
Net amount, premiums earned
$ 12,334 $ 12,047 $ 62,241
[1] Represents the sumface value outstanding of the in force life reinsurance policies.
Schedule VI - Sup... |
1 | 172412765_b1 | 172412765 | 620,902 2,516,917 2,522,791 2,457,075 2,434,037 2,532,212 2,354,610 10,336,612 9,777,934 8,226,425
Percentage of amount assumed to net
49.70% 44.40% 45.90%
Property and casualty operations
Total premiums earned:
Direct amount, premiums earned
$
$
$
9,078,575 9,142,690 7,717,173
Ceded to other companies, premi... |
1 | 172413477_0 | 172413477 | Venator Materials PLC
Form 10-K
Filed on 23-Feb-2018 Period 31-Dec-2017 Accession number: 0001558370-18-001041
Included Items
1. 10-K 2. EX-10.21 3. EX-10.22 4. EX-21.1 5. EX-23.1 6. EX-31.1 7. EX-31.2 8. EX-32.1 9. EX-32.2 10. XBRL (render)
Table of Contents
UNITED STATES SECURITIES AND EXCHANGECOMMISSION
Washing... |
1 | 172413477_1 | 172413477 | or other jurisdiction of incorporation or organization)
98 1373159 (I.R.S. Employer Identification No.)
Titanium House, Hanzard Drive, Wynyard Park, Stockton-On-Tees, TS22, 5FD, United Kingdom
+44 (0) 1740 608 001 (Address, including zip code, and telephone number, including area code, of registrant's principal exec... |
1 | 172413477_2 | 172413477 | Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES NO
Indicate by check mark whether the registrant has submitted electronically and posted o... |
1 | 172413477_3 | 172413477 | "accelerated filer" and "smaller reporting company" in Rule 12b 2 of the Exchange Act. (Check one):
Large accelerated filer
Accelerated filer
Non-accelerated
Smaller reporting
filer
company
(Do not check if a smaller reporting company)
Emerging growth company
If an emerging growth company, indicate by ch... |
1 | 172413477_b0 | 172413477 |
(Loss) income from continuing operations attributable to Venator Materials PLC ordinary shareholders
$ 0.64
$ 0.48
$ 0.29
$
(0.23)
$ (0.06)
$ (0.07)
$ (0.25)
$ (0.52) $ 1.19
$ (0.89) $ (3.47)
Net (loss) income attributable to Venator Materials PLC ordinary shareholders
0.64 0.48 0.29 (0.15) (0.06) (0.05) (... |
1 | 172413477_b1 | 172413477 |
SELECTED UNAUDITED QUARTERLY
FINANCIAL DATA
Revenue
$ 528 $ 582 $ 562 $ 537 $ 491 $ 532 $ 576 $ 540 $ 2,209 $ 2,139 $ 2,162
Cost of goods sold
387 446 479 463 440 491 543 513 1,738 1,987 2,046
Restructuring, impairment and plant closing and transition costs
3
16 7
26 4
7
13 11 52 35 220
(Loss) income from ... |
1 | 172414102_0 | 172414102 | Prothena Corp Plc
Form 10-K
Filed on 26-Feb-2018 Period 31-Dec-2017 Accession number: 0001559053-18-000008
Included Items
1. 10-K: FORM 10-K 2. EX-21.1: EXHIBIT 21.1 LIST OF
SUBSIDIARIES 3. EX-23.1: EXHIBIT 23.1 CONSENT OF KPMG
LLP 4. EX-31.1: EXHIBIT 31.1 CERTIFICATION OF
CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION ... |
1 | 172414102_1 | 172414102 | 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the year ended December 31, 2017
¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number: 001-35676 ______________________________________
PROTHENA CORPORATION PUBLIC LIMITED CO... |
1 | 172414102_2 | 172414102 | ) of the Act: None ______________________________________
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes x No o
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o... |
1 | 172414102_3 | 172414102 | Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. x
Indicate by check mark whether the registrant is a large accelerated fil... |
1 | 172414102_b0 | 172414102 |
SPAIN
Defined Contribution Plan Disclosure [Line Items]
Defined Contribution Plan, Employer Contribution, Percent of Employees' Gross Pay 7.50%
Related Parties (Detail) USD ($)
12 Months Ended Dec. 31, 2017 Dec. 31, 2016
Chief Regulatory Officer [Member]
Related Party Transaction [Line Items]
Amount paid to Re... |
1 | 172414102_b1 | 172414102 | er Contribution, Percent of Employees' Gross Pay 3.00%
Recorded expense for employer contributions
$ 700
$ 600
$ 400
EUROPE
Defined Contribution Plan Disclosure [Line Items]
Recorded expense for employer contributions
$ 352
$ 92
$ 51
IRELAND
Defined Contribution Plan Disclosure [Line Items]
Defined Contrib... |
1 | 172415686_0 | 172415686 | Intelsat S.A.
Form 20-F
Filed on 26-Feb-2018 Period 31-Dec-2017 Accession number: 0001193125-18-058405
Included Items
1. 20-F 2. EX-1.1 3. EX-8.1 4. EX-12.1 5. EX-12.2 6. EX-13.1 7. EX-13.2 8. EX-15.1 9. XBRL (render)
Table of Contents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 2... |
1 | 172415686_1 | 172415686 | PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission file number: 001-35878
INTELSAT S.A.
(Exact name of Registrant as specified in its charter)
N/A
(Translation of Registrant's name into English)
Grand Duchy of Luxembourg
(Jurisdiction of incorporation or organization)
4 rue Albert Bors... |
1 | 172415686_2 | 172415686 | Exchange
Securities registered or to be registered pursuant to Section 12(g) of the Act: None
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None
Indicate the number of outstanding shares of each of the issuer's classes of capital or common stock as of the close of the pe... |
1 | 172415686_3 | 172415686 | months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data F... |
1 | 172415686_b0 | 172415686 |
8,724
Other payments for satellites
35,396
Capital contribution from parent
(108,153)
Dividends to shareholders
1,064,088
Principal payments on deferred satellite performance incentives
37,186
Restricted cash for collateral
1,901
Other financing activities
Net cash provided by (used in) financing activitie... |
1 | 172415686_b1 | 172415686 | 414,339 256,619
89,641 414,339
63,144 89,641
Consolidation and Eliminations [Member]
Condensed Cash FlowStatements, Captions [Line Items]
Cash flows from operating activities:
(780,309)
Cash flows from investing activities:
Payments for satellites and other property and equipment (including capitalized interest... |
1 | 172416369_0 | 172416369 | SYNTEL INC
Form 10-K
Filed on 26-Feb-2018 Period 31-Dec-2017 Accession number: 0001193125-18-058590
Included Items
1. 10-K 2. EX-10.22 3. EX-10.23 4. EX-21 5. EX-23 6. EX-31.1 7. EX-31.2 8. EX-31.3 9. EX-32 10. XBRL (render)
Table of Contents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
... |
1 | 172416369_1 | 172416369 | , Troy, Michigan
(Address of principal executive offices)
Registrant's telephone number, including area code: (248) 619-2800
48083
(Zip Code)
Securities registered pursuant to Section 12(b) of the Act:
Title of Class
Common Stock, no par value
Name of Exchange on Which Registered
The NASDAQ Global Select Market
Se... |
1 | 172416369_2 | 172416369 | mark whether the Registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post suc... |
1 | 172416369_3 | 172416369 |
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. Indicate by check mark whether the Reg... |
1 | 172416369_b0 | 172416369 | Dec. 31, 2016
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Term deposits outstanding
$ 1.2
$ 6.8
Short term investments
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Term deposits outstanding
0.8
6.6
Non-current assets
Sc... |
1 | 172416369_b1 | 172416369 | Measured on Recurring and Nonrecurring Basis [Line Items]
Available for sale securities
$ 25.7
$ 15.0
Term Deposits
1.2
6.8
Interest Rate Swap
3.3
0.5
Total Assets Measured at Fair Value
30.2
22.3
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Availa... |
1 | 172418249_0 | 172418249 | Oxford Immunotec Global PLC
Form 10-K
Filed on 27-Feb-2018 Period 31-Dec-2017 Accession number: 0001437749-18-003397
Included Items
1. 10-K: FORM 10-K 2. EX-10.5: EXHIBIT 10.5 3. EX-10.21: EXHIBIT 10.21 4. EX-10.33: EXHIBIT 10.33 5. EX-10.44: EXHIBIT 10.44 6. EX-10.50: EXHIBIT 10.50 7. EX-21.1: EXHIBIT 21.1 8. EX-23.... |
1 | 172418249_1 | 172418249 | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THESECURITIES EXCHANGEACT OF 1934 For the fiscal year ended December 31, 2017 OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THESECURITIES EXCHANGEACT OF 1934 For the transition period from to Commission File Number 001-36200
OXFORD IMMUNOTEC GLOBAL PLC
(Exact n... |
1 | 172418249_2 | 172418249 | Securities registered pursuant to Section 12(g) of the Act None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes No ... |
1 | 172418249_3 | 172418249 | 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.
Indicate by check mark whether the registrant is a large accelerat... |
1 | 172418249_b0 | 172418249 | 2016 Dec. 31, 2015
Total revenues
$ 92,860 $ 75,622
Net loss
$ (21,840) $ (25,281)
Net loss per share--basic and diluted (in dollars per share)
$ (0.98) $ (1.16)
Weighted average shares outstanding--basic and diluted (in shares) 22,353,713 21,781,933
Note 18 - Restructuring (Details Textual) - Plan to Termina... |
1 | 172418249_b1 | 172418249 | 284,000) 8,122,000 1,322,000 9,444,000
Assets acquired: Intangible assets Immunetics [Member] | Customer Relationships [Member] Assets acquired: Intangible assets Immunetics [Member] | Trade Names [Member] Assets acquired: Intangible assets Immunetics [Member] | Grants [Member] Assets acquired: Intangible assets Immu... |
1 | 172419026_0 | 172419026 | Endo International Plc
Form 10-K
Filed on 27-Feb-2018 Period 31-Dec-2017 Accession number: 0001593034-18-000010
Included Items
1. 10-K: 2017 10-K 2. EX-21.1: SUBSIDIARIES 3. EX-23.1: CONSENT OF PWC 4. EX-24: POWER OF ATTORNEY 5. EX-31.1: CEO SECTION 302 CERTIFICATION 6. EX-31.2: CFO SECTION 302 CERTIFICATION 7. EX-32... |
1 | 172419026_1 | 172419026 |
or
o TRANSITION REPORTPURSUANTTO SECTION 13 OR 15(d) OF THESECURITIES EXCHANGEACTOF 1934.
FOR THETRANSITION PERIOD FROM
TO
Commission File Number: 001-36326
____________________________________________________________________________________________
ENDO INTERNATIONAL PLC
(Exact name of registrant as specified ... |
1 | 172419026_2 | 172419026 |
____________________________________________________________________________________________
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d)... |
1 | 172419026_3 | 172419026 | 's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.
Yes þ No o Yes o No þ Yes þ No o Yes þ No o
þ
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated file... |
1 | 172419026_b0 | 172419026 | $ 1,140,709
Acquisition-related and integration items
26,400 16,600 4,200 10,900 7,400 19,500 48,200 12,600 58,086 87,601 105,250
Change in fair consideration
value
of
contingent
26,400
15,400 2,000
6,200 (1,000) 11,600 23,900 (10,700) 49,949 23,823 (65,640)
Severance costs
84,500 80,700 24,600 22,700 37,100... |
1 | 172419026_b1 | 172419026 | dollars per share) $ (1.65) $ (0.43) $ (6.26) $ (0.78) $ (14.98) $ (0.98) $ 1.54 $ (0.60) $ (9.12) $ (15.03) $ (7.59)
Weighted (shares)
average
shares--Basic
223,322
223,299 223,158
223,014 222,870
222,767 222,667 222,302 223,198
222,651
197,100
Weighted average shares-- Diluted (shares)
223,322 223,299 223... |
1 | 172421352_0 | 172421352 | Mallinckrodt Plc
Form 10-K
Filed on 27-Feb-2018 Period 29-Dec-2017 Accession number: 0001567892-18-000010
Included Items
1. 10-K 2. EX-10.9: EXHIBIT 10.9 3. EX-10.29: EXHIBIT 10.29 4. EX-21.1: EXHIBIT 21.1 5. EX-23.1: EXHIBIT 23.1 6. EX-31.1: EXHIBIT 31.1 7. EX-31.2: EXHIBIT 31.2 8. EX-32.1: EXHIBIT 32.1 9. XBRL (ren... |
1 | 172421352_1 | 172421352 | OF THESECURITIES EXCHANGEACT OF 1934 For the transition period from _____ to _____
Commission File Number : 001-35803 _________________________________
Mallinckrodt public limited company
(Exact name of registrant as specified in its charter) _________________________________
Ireland
(State or other jurisdiction of ... |
1 | 172421352_2 | 172421352 | by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o No x
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 duringthe preceding12 months (or for ... |
1 | 172421352_3 | 172421352 | 10-K or any amendment to this Form 10-K. o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reportingcompany, or an emerginggrowth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reportingcompan... |
1 | 172421352_b0 | 172421352 | . 30, 2016 Dec. 29, 2017 Sep. 30, 2016 Sep. 25, 2015
Allowance for doubtful accounts
Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Period
$ 4.0
$ 4.0
$ 3.6
$ 2.2
Charged to Income
0.1
0.6
0.3
1.2
Additions and Other
0.0
0.0
0.0
0.0
Deductions
(0.1)
(0.7)
(0.1)... |
1 | 172421352_b1 | 172421352 | 000 100,000,000
$ 300,000,000 3.25% $ 1,000
$ 225,000,000
1,851,200,000 1,837,200,000 0
Event [Member] Subsequent Event [Line Items] Long-term Debt, Gross
Proceeds from Lines of Credit Receivable securitization, Maturity Date of July 2020 [Member] | Secured Debt Subsequent Event [Line Items] Variable interest rate ... |
1 | 172421358_0 | 172421358 | FRANK's INTERNATIONAL N.V.
Form 10-K
Filed on 27-Feb-2018 Period 31-Dec-2017 Accession number: 0001575828-18-000007
Included Items
1. 10-K 2. EX-10.14: EXHIBIT 10.14 3. EX-10.15: EXHIBIT 10.15 4. EX-10.19: EXHIBIT 10.19 5. EX-10.20: EXHIBIT 10.20 6. EX-10.55: EXHIBIT 10.55 7. EX-18.1: EXHIBIT 18.1 8. EX-21.1: EXHIBIT... |
1 | 172421358_1 | 172421358 | OMMISSION
Washington, D.C. 20549 FORM 10-K (Mark One)
þ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the fiscal year ended December 31, 2017
OR
¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from ______ to ... |
1 | 172421358_2 | 172421358 |
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ¨ No þ
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the A... |
1 | 172421358_3 | 172421358 | mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of the registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment... |
1 | 172421358_b0 | 172421358 |
$ 162,501 61,526
$ 223,222 $ 246,652 $ 384,842 $ 87,200 70,616 129,748
117,884 34,412
178,865 45,162
201,316 304,473 $ 59,037 $ 113,918
(10,884) $ 10,884
(16,364) $ 16,364
Schedule II - Valuation and Qualifying Account (Details) -
USD ($) $ in Thousands
12 Months Ended Dec. 31, 2017 Dec. 31, 2016 Dec. 31, 201... |
1 | 172421358_b1 | 172421358 | Accounts receivable write-offs
$ 15,022
$ 15,022 $ 0 $ 0
Quarterly Financial Data (Unaudited) - Blackhawk Reclassifications (Details) -
USD ($) $ in Thousands
Business Acquisition [Line Items] Services Products As previously reported
Business Acquisition [Line Items] Services Products Blackhawk | Blackhawk adjustme... |
1 | 172422510_0 | 172422510 | Horizon Pharma Plc
Form 10-K
Filed on 28-Feb-2018 Period 31-Dec-2017 Accession number: 0001564590-18-003661
Included Items
1. 10-K 2. EX-10.6 3. EX-10.30 4. EX-10.53 5. EX-10.68 6. EX-10.69 7. EX-10.70 8. EX-10.71 9. EX-10.72 10. EX-21.1 11. EX-23.1 12. EX-31.1 13. EX-31.2 14. EX-32.1 15. EX-32.2 16. XBRL (render)
... |
1 | 172422510_1 | 172422510 | URITIES EXCHANGEACT OF 1934
For the transition period from
to
Commission File Number 001-35238
HORIZON PHARMA PUBLIC LIMITED COMPANY
(Exact name of Registrant as specified in its charter)
Ireland
(State or other jurisdiction of incorporation or organization)
Not Applicable
(I.R.S. Employer Identification No.)
Co... |
1 | 172422510_2 | 172422510 | icate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes No.
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (o... |
1 | 172422510_3 | 172422510 |
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.
Large accelerated filer
Accelerated filer
Non-accelerated filer
(Do not check if a smaller reporting company)
Smaller reporti... |
1 | 172422510_b0 | 172422510 | 48 537,542
Operating (loss) income
(75,568) (25,751) (185,667) (105,383) (130,108) (21,322) 31,467
(27,204)
$ (392,369)
$ (147,167)
$
55,372
Net (loss) income
$ (46,449)
$ (63,971)
$
$
(209,536) (90,570)
$ (130,542)
$
(5,870)
$
14,984
$ (45,406)
Net (loss) income per ordinary share basic
$ (0.28)
... |
1 | 172422510_b1 | 172422510 | ]
Percent of matching contribution by company
50.00%
Selected Quarterly Financial Information (Unaudited) Summary of Selected Financial Results of
Operations (Detail) - USD ($) $ / shares in Units, $ in
3 Months Ended
12 Months Ended
Dec. 31, Sep. 30, Jun. 30, Mar. 31, Dec. 31, Sep. 30, Jun. 30, Mar. 31, Dec. 31... |
1 | 172423835_0 | 172423835 | Eaton Corp Plc
Form 10-K
Filed on 28-Feb-2018 Period 31-Dec-2017 Accession number: 0001551182-18-000074
Included Items
1. 10-K 2. EX-4.4: EXHIBIT 4.4 3. EX-4.5: EXHIBIT 4.5 4. EX-4.6: EXHIBIT 4.6 5. EX-12: EXHIBIT 12 6. EX-18: EXHIBIT 18 7. EX-21: EXHIBIT 21 8. EX-23: EXHIBIT 23 9. EX-24: EXHIBIT 24 10. EX-31.1: EXHI... |
1 | 172423835_1 | 172423835 | pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the year ended December 31, 2017 Commission file number 000-54863
EATON CORPORATION plc
(Exact name of registrant as specified in its charter)
Ireland (State or other jurisdiction of incorporation or organization)
98-1059235 (IRS Employer Id... |
1 | 172423835_2 | 172423835 | check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the ... |
1 | 172423835_3 | 172423835 | , a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer þ Smaller reporting company o
... |
1 | 172423835_b0 | 172423835 | beginning of the period Cash at the end of the period Consolidating adjustments Condensed Consolidating Statements of Cash Flows [Line Items] Net cash provided by (used in) operating activities Investing activities Capital expenditures for property, plant and equipment Cash received from (paid for) acquisitions of bus... |
1 | 172423835_b1 | 172423835 | 0 0 0
0 (1,250)
0 0 3,843 (646) 0 0 0 (1,037)
74 (730) 0 0 1,504 0 1 0 1
22
(92) 0 0 0 0 (251) 1,293
(9) 941
21 (408) 4,045 (4,712) 0 0
(137)
0 0 0 (1,482)
0 0 0 0 (1,482)
0 0 3,322 (48) 0
0 (1,026) 0 52 (682) 0 0 1,618 0 (1) 1 0
(195)
(94) 0 0 0
(889) 342 0 (50) (691)
408 (724) 6,885 (6,467) 1,176
Other intercompa... |
1 | 172424023_0 | 172424023 | ROWAN COMPANIES PLC
Form 10-K
Filed on 28-Feb-2018 Period 31-Dec-2017 Accession number: 0000085408-18-000039
Included Items
1. 10-K 2. EX-21: EXHIBIT 21 3. EX-23: EXHIBIT 23 4. EX-24: EXHIBIT 24 5. EX-31.1: EXHIBIT 31.1 6. EX-31.2: EXHIBIT 31.2 7. EX-32.1: EXHIBIT 32.1 8. EX-32.2: EXHIBIT 32.2 9. XBRL (render)
Tabl... |
1 | 172424023_1 | 172424023 | __________ to __________ Commission File Number: 1-5491
Rowan Companies plc
(Exact name of registrant as specified in its charter)
England and Wales (State or other jurisdiction of incorporation or organization)
98-1023315 (I.R.S. Employer Identification No.)
2800 Post Oak Boulevard, Suite 5450 Houston, Texas 7705... |
1 | 172424023_2 | 172424023 | the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ... |
1 | 172424023_3 | 172424023 | non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of "large accelerated filer," "accelerated filer", "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act. Large accelerated filer þ Accelerated filer ¨ Non-accelerated filer ¨ Smalle... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.